JRJ
HZNP

Jeffrey R. Jay’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jeffrey R. Jay’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$3.93M Buy
+1,596,720
New +$3.83M 3.1% 11

Other funds holding HZNP

MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jeffrey R. Jay's HZNP Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2013: 1,596,720 shares worth $3.93M. The stake represents 3.1% of the portfolio and ranks #11 among its holdings.

59 funds tracked by Wall St. Rank hold HZNP as of Q2 2013.

  • Jeffrey R. Jay held 1,596,720 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $3.93M as of Q2 2013.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new Jeffrey R. Jay position in Q2 2013.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 3.1% of Jeffrey R. Jay's portfolio in Q2 2013, its #11 holding.
  • 59 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.